Literature DB >> 2070231

Pyoderma gangrenosum in inflammatory bowel disease.

M D Levitt1, J K Ritchie, J E Lennard-Jones, R K Phillips.   

Abstract

Since 1954, 34 patients have attended St. Mark's Hospital with pyoderma gangrenosum in association either with ulcerative colitis (22 patients) or Crohn's disease (12 patients). Lesions were multiple in 71 per cent and over half were situated below the knees. Ulcerative colitis was active in 11 patients (50 per cent) and Crohn's disease was active in nine (75 per cent) when pyoderma gangrenosum was diagnosed. Associated illnesses--most commonly a seronegative arthritis affecting large joints--were present in 55 per cent and 92 per cent of cases respectively. A diffuse pustular rash appeared in six patients, synchronously with pyoderma in five. In a further seven patients (two with ulcerative colitis, five with Crohn's disease) the onset or course of pyoderma might have been linked to the presence of non-dermatological suppuration. Pyoderma resolved without intestinal resection in two-thirds of patients. When present at the time of surgical resection (15 procedures in 13 patients), pyoderma healed promptly in six cases, only with additional therapy in four cases and very slowly or not at all in five cases. Pyoderma gangrenosum occurs in both ulcerative colitis and Crohn's disease. Healing after intestinal resection is unpredictable both with respect to timing and extent of resection.

Entities:  

Mesh:

Year:  1991        PMID: 2070231     DOI: 10.1002/bjs.1800780613

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

1.  Pyoderma gangrenosum: a rare cause of breast ulceration.

Authors:  Georgina Duke; Ahmad Al Samaraee; Akhtar Husain; Simon Meggitt; Tarannum Fasih
Journal:  Ochsner J       Date:  2012

Review 2.  Biological therapy for dermatological manifestations of inflammatory bowel disease.

Authors:  Maddalena Zippi; Roberta Pica; Daniela De Nitto; Paolo Paoluzi
Journal:  World J Clin Cases       Date:  2013-05-16       Impact factor: 1.337

3.  Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: rapid disappearance with methylprednisolone.

Authors:  Paolo Aseni; Stefano Di Sandro; Plamen Mihaylov; Luca Lamperti; Luciano-Gregorio De Carlis
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Refractory, disfiguring vulvar pyoderma gangrenosum and Crohn's disease.

Authors:  M L Borum; M Cannava; C Myrie-Williams
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 6.  Important cutaneous manifestations of inflammatory bowel disease.

Authors:  L B Trost; J K McDonnell
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 7.  Skin Manifestations of Inflammatory Bowel Disease.

Authors:  Thomas Greuter; Alexander Navarini; Stephan R Vavricka
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

8.  Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.

Authors:  Mark S Sapienza; Sidney Cohen; Anthony J Dimarino
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 9.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

10.  Intestinal Behcet's disease with pyoderma gangrenosum: a case report.

Authors:  Toshio Nakamura; Hiroaki Yagi; Kiyotaka Kurachi; Shohachi Suzuki; Hiroyuki Konno
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.